I look at the Nuffield report that relates to these two conflicting petitions, and it makes it clear that we cannot go on delivering these services in a hospital building that is well past its sell-by date. If we want to improve cancer survival rates for the population of south-east Wales, we really do have to take things forward now, and we can't go on delaying decisions.

It has to be—. Redevelopment has to be a vehicle for reshaping services to better meet patients' needs, including being treated closer to home, but still getting that expertise concentrated at a Velindre centre. Velindre is a stand-alone trust for a reason. It is not part of a health board, because it has to have a culture that is quite distinct. The word 'cancer' alone causes terror in many people's minds, so one of the most important things that Velindre does is to reassure patients that, in most cases, cancer is not a death sentence. But the treatment of cancer is not a mechanical process, and a positive attitude and a focus on the quality of life is an essential part of the treatment and care process. And patients and their families need to be supported with the decision that is right for them in their particular circumstances.

So, this is not a Cardiff service; this is a service for the whole of south-east Wales. And whilst the majority of its services are either ambulatory chemotherapy, which can be delivered elsewhere and, as far as I understand, is, its radiotherapy services are, at the moment, concentrated at Velindre, because the cost of building these linear accelerators—LINACs, apparently, they're called—is a huge capital investment, very expensive and has to be built in a massive concrete bunker. So, up to now, all these LINACs have been at Velindre. But I note that the new Velindre plan includes one LINAC at Nevill Hall, and of course that is really important for patients, because it reduces the travel burden for patients and their carers, and, when you're unwell, that's really important. And it's also part of our attempt to tackle the inverse care law. 

Clearly, it's really important that this should not just be consumed by any general hospital, and, for me, the idea of building on the Heath site at the moment seems completely impossible. The Heath site is incredibly busy. Until recently, it was being used as a rat run for commuters, and the Nuffield report is quite clear that at the moment, this is just not an option. Maybe when we have a new University Hospital of Wales, then maybe you could see some sort of incorporation on the same site, but co-location cannot mean absorption. So, it seems to me that if Cardiff University want to build a new cancer research centre, I don't understand why they aren't thinking of co-locating it with Velindre, which is currently not possible on the Heath site. You can't deliver a new Velindre centre while you're also delivering patient care to sick people, so it seems to me that the closure of the Whitchurch hospital does provide a golden opportunity to build back better an environmentally sensitive centre of excellence in line with some of the points made—